Daily Ards Research Analysis
Three studies advance bedside decision-making in respiratory failure: a multicenter prospective analysis shows a simplified midclavicular lung ultrasound score accurately predicts early surfactant need in neonatal RDS; a retrospective ARDS cohort links low lung compliance and dynamic oxygenation changes to HFNC failure; and an ECMO cohort identifies vasopressor exposure as a key risk factor for AKI with heparin showing a protective association.
Summary
Three studies advance bedside decision-making in respiratory failure: a multicenter prospective analysis shows a simplified midclavicular lung ultrasound score accurately predicts early surfactant need in neonatal RDS; a retrospective ARDS cohort links low lung compliance and dynamic oxygenation changes to HFNC failure; and an ECMO cohort identifies vasopressor exposure as a key risk factor for AKI with heparin showing a protective association.
Research Themes
- Bedside prediction tools in respiratory failure
- Point-of-care ultrasound for neonatal RDS decision-making
- ECMO complications and organ protection strategies
Selected Articles
1. A Simplified, Regional Lung Ultrasound Score for Surfactant Administration in Neonatal RDS: A Prospective Observational Study.
In a multicenter prospective cohort of 175 preterm infants with RDS stabilized on nCPAP, regional lung ultrasound scores at midclavicular (MC) views strongly predicted early surfactant need. The combined left+right MC score achieved AUC 0.90 (sensitivity 0.82, specificity 0.89; Youden cut-off 3), outperforming individual views.
Impact: Provides a rapid, bedside, simplified ultrasound metric with high diagnostic accuracy, potentially reducing handling and radiographs in fragile preterm infants.
Clinical Implications: Adopting a combined MC lung ultrasound score (cut-off 3) can standardize early surfactant decisions in preterm RDS, reduce stressful repositioning for multiple views, and integrate with non-invasive indices (e.g., SatO2/FiO2) for workflow efficiency.
Key Findings
- Left MC score predicted surfactant need with AUC 0.86 (sensitivity 0.79, specificity 0.90).
- Right MC score predicted surfactant need with AUC 0.87 (sensitivity 0.74, specificity 0.93; optimal Youden cut-off = 2).
- Combined left + right MC score achieved AUC 0.90 (sensitivity 0.82, specificity 0.89; optimal Youden cut-off = 3).
- An MC score ≥2 was an early marker of aeration heterogeneity in early RDS.
Methodological Strengths
- Multicenter prospective design with standardized ultrasound views
- Robust diagnostic accuracy analysis with AUC and Youden cut-offs
Limitations
- Secondary analysis; not a randomized interventional study
- Operator dependence and generalizability beyond participating centers require validation
Future Directions: Prospective trials testing LUS-guided surfactant strategies versus standard care, external validation across gestational ages and care settings, and integration into clinical decision algorithms.
BACKGROUND: A total lung ultrasound score (tLUS) is a validated tool to describe parenchymal aeration, evaluate neonatal respiratory distress syndrome (RDS) progression and guide early surfactant replacement. tLUS derives from regional scores (rLUS) from predefined ultrasound views. RESEARCH QUESTION: This paper explores the relative contribution of rLUS to tLUS and their predictive power of surfactant need for RDS, individually and with additional variables. STUDY DESIGN AND METHODS: This was a secondary analys
2. Combined lung compliance and oxygenation dynamics predict high-flow nasal cannula failure in acute respiratory distress syndrome: a retrospective cohort study.
In 154 ARDS patients receiving HFNC at flows ≥50 L/min, low baseline lung compliance and dynamic changes in oxygenation (ΔPaO2/FiO2) were associated with HFNC failure. Combining compliance with ΔPaO2/FiO2 provided a pragmatic physiological approach to anticipate escalation needs.
Impact: Links easily obtainable bedside physiology to HFNC outcomes in ARDS, offering a practical framework for early intubation considerations.
Clinical Implications: Monitoring baseline lung compliance and ΔPaO2/FiO2 can help identify patients at high risk of HFNC failure, prompting timely escalation to invasive ventilation and optimizing ICU resource use.
Key Findings
- Low baseline lung compliance (<30 mL/cmH2O) was associated with HFNC failure in ARDS.
- Dynamic oxygenation changes (ΔPaO2/FiO2) were linked to HFNC outcomes.
- Combining lung compliance with ΔPaO2/FiO2 parameters predicted HFNC outcomes.
Methodological Strengths
- Objective physiological metrics (lung compliance, ΔPaO2/FiO2) tied to clinically meaningful outcomes
- Clear HFNC inclusion criteria (flow ≥50 L/min)
Limitations
- Single-center retrospective design with potential residual confounding
- Potential variability in compliance measurement and incomplete reporting limits external validation
Future Directions: Prospective multicenter validation and development of a bedside risk score integrating compliance, ΔPaO2/FiO2, and other physiologic markers to guide escalation decisions.
OBJECTIVES: To evaluate the combined predictive value of lung compliance and dynamic oxygenation parameters for high-flow nasal cannula (HFNC) outcomes. METHODS: In this single-center retrospective cohort study, 154 patients with acute respiratory distress syndrome (ARDS) treated with HFNC (flow ≥50 L/min, fraction of inspired oxygen [FiO RESULTS: Low baseline lung compliance (<30 mL/cmH CONCLUSIONS: The combination of lung compliance and ΔPaO
3. Factors associated with acute kidney injury in patients on extracorporeal membrane oxygenation support: A retrospective cohort study.
Among 267 adult ECMO patients (VA and VV), vasopressor use was strongly associated with AKI (norepinephrine OR 3.7; vasopressin OR 2.5), while heparin use (OR 0.51) and absence of vasopressors (OR 0.39) were protective. Findings highlight modifiable exposures to reduce renal complications during ECMO.
Impact: Identifies actionable risk and protective factors for AKI in ECMO patients, informing hemodynamic and anticoagulation strategies to mitigate renal injury.
Clinical Implications: Minimize vasopressor exposure where feasible, optimize perfusion targets, and consider anticoagulation strategies (e.g., heparin) while monitoring renal function to prevent AKI during ECMO.
Key Findings
- Norepinephrine use was associated with AKI (OR 3.7; 95% CI 1.65–8.14).
- Vasopressin use was associated with AKI (OR 2.5; 95% CI 1.49–4.30).
- Heparin use showed a protective association against AKI (OR 0.51; 95% CI 0.26–0.97).
- Absence of vasopressor use was protective (OR 0.39; 95% CI 0.17–0.77).
Methodological Strengths
- Moderate sample size with both VA and VV-ECMO included
- Multivariable analysis reporting adjusted odds ratios and 95% CIs
Limitations
- Retrospective single-center study limits causal inference and generalizability
- Potential confounding by indication (sicker patients receive vasopressors); ECMO mode heterogeneity
Future Directions: Prospective studies to test vasopressor-sparing protocols and renal-protection bundles in ECMO, and mechanistic work to elucidate AKI pathways under extracorporeal circulation.
IntroductionAcute kidney injury (AKI) is prevalent in critically ill patients, especially in those needing extracorporeal membrane oxygenation (ECMO) due to cardiogenic shock or acute respiratory distress syndrome. The incidence of AKI in this patient population varies from 26% to 85%. This study explored the factors associated with AKI after the initiation of ECMO in the intensive care unit (ICU).MethodsA retrospective cohort study was conducted, including patients aged 18 years and above undergoing veno-arterial or veno-venous ECMO between 1 January, 2020 and 1 May, 2023.ResultsA total of 267 patients undergoing ECMO were included in this study. The development of AKI was associated with the use of vasopressors, specifically norepinephrine (odds ratio [OR]: 3.7, 95% confidence interval [95% CI]: 1.65-8.14) and vasopressin (OR: 2.5, 95% CI: 1.49-4.30).The protective factors included heparin use (OR: 0.51, 95% CI: 0.26-0.97) and the absence of vasopressors (OR: 0.39, 95% CI: 0.17-0.77).ConclusionsAKI poses a significant concern in critically ill patients undergoing ECMO. Multiple risk factors were identified, including vasopressor use and ECMOrelated complications. Identifying risks and protective factors is crucial for optimising ECMO management to reduce complications and mortality risk. Further studies are needed to understand the exact mechanisms of AKI during ECMO, which can inform the development of new targeted intervention checkpoints to improve outcomes in critically ill patients undergoing ECMO.